These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3663621)

  • 1. Inhibition of cholesterol biosynthesis by fluorinated mevalonate analogues.
    Reardon JE; Abeles RH
    Biochemistry; 1987 Jul; 26(15):4717-22. PubMed ID: 3663621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of mevalonate pyrophosphate decarboxylase: evidence for a carbocationic transition state.
    Dhe-Paganon S; Magrath J; Abeles RH
    Biochemistry; 1994 Nov; 33(45):13355-62. PubMed ID: 7947744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of the inhibition of cholesterol biosynthesis by 6-fluoromevalonate.
    Nave JF; d'Orchymont H; Ducep JB; Piriou F; Jung MJ
    Biochem J; 1985 Apr; 227(1):247-54. PubMed ID: 2986604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifunctional inhibitors of mevalonate kinase and mevalonate 5-diphosphate decarboxylase.
    Qiu Y; Li D
    Org Lett; 2006 Mar; 8(6):1013-6. PubMed ID: 16524256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of rat liver mevalonate pyrophosphate decarboxylase and mevalonate phosphate kinase by phenyl and phenolic compounds.
    Shama Bhat C; Ramasarma T
    Biochem J; 1979 Jul; 181(1):143-51. PubMed ID: 226078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver mevalonate 5-pyrophosphate decarboxylase is responsible for reduced serum cholesterol in stroke-prone spontaneously hypertensive rat.
    Sawamura M; Nara Y; Yamori Y
    J Biol Chem; 1992 Mar; 267(9):6051-5. PubMed ID: 1556116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sites of control of hepatic cholesterol biosynthesis.
    Gould RG; Swyryd EA
    J Lipid Res; 1966 Sep; 7(5):698-707. PubMed ID: 5971049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of mevalonate- and fluorinated mevalonate prodrugs and their in vitro human plasma stability.
    Kang S; Watanabe M; Jacobs JC; Yamaguchi M; Dahesh S; Nizet V; Leyh TS; Silverman RB
    Eur J Med Chem; 2015 Jan; 90():448-61. PubMed ID: 25461893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of cholestyramine feeding on mevalonate-activating enzymes.
    Gonzalez-Pacanowska D; Marco C; Iglesias J; Garcia-Martinez J; Garcia-Peregrin E
    Enzyme; 1988; 39(2):90-4. PubMed ID: 2840276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural analysis of mevalonate-3-kinase provides insight into the mechanisms of isoprenoid pathway decarboxylases.
    Vinokur JM; Korman TP; Sawaya MR; Collazo M; Cascio D; Bowie JU
    Protein Sci; 2015 Feb; 24(2):212-20. PubMed ID: 25422158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of fatty acid biosynthesis by intermediates of the cholesterol biosynthetic pathway.
    Ku EC
    Biochem Biophys Res Commun; 1996 Aug; 225(1):173-9. PubMed ID: 8769113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mevalonic acid analogs as inhibitors of cholesterol biosynthesis.
    DeBold CR; Elwood JC
    J Pharm Sci; 1981 Sep; 70(9):1007-10. PubMed ID: 6101142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate binding order in mevalonate 5-diphosphate decarboxylase from chicken liver.
    Jabalquinto AM; Cardemil E
    Biochim Biophys Acta; 1989 Jul; 996(3):257-9. PubMed ID: 2752048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polychlorinated biphenyls: in vivo and in vitro modifications of cholesterol and fatty acid biosynthesis.
    Kling D; Kunkle J; Roller AS; Gamble W
    J Environ Pathol Toxicol; 1978; 1(6):813-28. PubMed ID: 32219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mevalonate 5-diphosphate decarboxylase by fluorinated substrate analogs.
    Qiu Y; Li D
    Biochim Biophys Acta; 2006 Jul; 1760(7):1080-7. PubMed ID: 16626865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary regulatory sites in rat liver cholesterol biosynthesis: role of 5-pyrophosphomevalonate decarboxylase.
    Jabalquinto AM; Cardemil E
    Lipids; 1980 Mar; 15(3):196-8. PubMed ID: 7374372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mevalonate-5-pyrophosphate decarboxylase in the regulation of chick intestinal cholesterogenesis.
    Gonzalez-Pacanowska D; Marco C; Garcia-Martinez J; Garcia-Peregrin E
    Biochim Biophys Acta; 1985 Mar; 833(3):449-55. PubMed ID: 4038608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of phenylalanine derivatives on the main regulatory enzymes of hepatic cholesterogenesis.
    Castillo M; Martinez-Cayuela M; Zafra MF; Garcia-Peregrin E
    Mol Cell Biochem; 1991 Jun; 105(1):21-5. PubMed ID: 1922006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in cholesterol and fatty acid biosynthesis in rat liver homogenates by aryloxy acids.
    Olson RJ; Trumble TE; Gamble W
    Biochem J; 1974 Aug; 142(2):445-8. PubMed ID: 4441387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of bacterial mevalonate diphosphate decarboxylase by eriochrome compounds.
    Skaff DA; McWhorter WJ; Geisbrecht BV; Wyckoff GJ; Miziorko HM
    Arch Biochem Biophys; 2015 Jan; 566():1-6. PubMed ID: 25499551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.